Singapore Contraceptive Devices Market Report 2022 to 2030

Singapore Contraceptive Devices Market Analysis

$ 3999

Singapore's Contraceptive Devices Market is expected to grow from $15 Mn in 2022 to $30 Mn in 2030 with a CAGR of 8.60% for the forecasted year 2022-30. In Singapore, the use of contemporary contraceptive techniques such as hormonal contraceptives and LARCs has been rising. This pattern is predicted to persist, creating a growing opportunity for producers of cutting-edge contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Biosensors International, Everlife, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10SGMD005 CATEGORY: Medical Devices GEOGRAPHY: Singapore AUTHOR: Jigyasu Bhandari

Buy Now

Singapore Contraceptive Devices Healthcare Market Executive Analysis

Singapore's Contraceptive Devices Market is expected to grow from $15 Mn in 2022 to $30 Mn in 2030 with a CAGR of 8.60% for the forecasted year 2022-30. Singapore's government is going to spend $13.65 billion on healthcare in 2023, and $36 billion in 2029. The healthcare industry in Singapore is anticipated to grow by 9%, from $21.4 billion in 2017 to $23 billion in 2023. By 2029, it is expected that the industry will have more than doubled, reaching $49.4 billion. In Singapore, it is expected that healthcare spending, which includes both public and private expenses, will account for 5.9% of GDP in 2019 and up to 9% by 2029.

In Singapore, a total of 34,666 cases of sexually transmitted infections occurred in 2020, an increase of 4.7% from the year before. With roughly 60% of all reported cases in 2020, chlamydia is going to be the most frequent STI in Singapore. Syphilis is the most often reported STI, followed by gonorrhea. There were 295 new HIV infections recorded overall in 2020. Condoms, intrauterine devices, and hormonal birth control tablets are among the contraceptive methods with the highest success rates in avoiding unwanted pregnancies. As a result, parents-to-be can better plan and get ready individually and as a couple. Women may have more control over their overall lives and reproductive decisions with the aid of contraceptive methods. This may aid in advancing gender equality and easing the burden of unintended pregnancy on women. Some contraceptive methods, including condoms, provide STI protection as well, which can slow the development of these infections in Singapore. Contraception methods like sterilization and abortion are often more expensive than contraceptive devices.

Singapore Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Singapore, the use of contemporary contraceptive techniques such as hormonal contraceptives and LARCs has been rising. This pattern is predicted to persist, creating a growing opportunity for producers of cutting-edge contraceptive methods. Contraceptive technology improvements have improved the efficacy and use of these devices. For instance, the introduction of long-acting reversible contraceptives such as contraceptive implants and intrauterine devices has increased. The Singaporean government has started a number of programmes to promote contraception and family planning. For instance, the government offers subsidies for particular contraceptive methods, lowering the cost to users. As a result, there is now a higher need for contraceptive products, which presents a chance for producers to expand.

Market Restraints

In Singapore, contraceptive devices are subject to strict regulations from the Singaporean government. These regulations must be followed by manufacturers, which can be expensive and time-consuming. For new market entrants, this may serve as a barrier. Contraceptive products are freely accessible on the market and can cost less than name-brand alternatives. Manufacturers who are unable to compete on pricing may find that this limits their market potential.

Competitive Landscape

Key Players

Biosensors International (SG)
Everlife (SG)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

Singapore has a prominent healthcare system and a thorough regulatory framework for contraceptive devices. The Health Sciences Authority (HSA), which is in charge of regulating the efficacy, quality, and safety of contraceptive devices in Singapore, is in charge of overseeing the regulatory framework. Pre-market approval procedures, post-market surveillance, and continuous safety and efficacy monitoring are all part of Singapore's regulatory system for contraceptive devices. Before launching their products in Singapore, contraceptive device manufacturers must receive clearance from the HSA. The National Family Planning Programme of the Singaporean government intends to offer complete family planning services to Singaporean individuals and couples. The programme offers payments for certain contraceptive methods as well as family planning and contraception education and counselling.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.